-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DBRUUeL6xK4F6/ncZMbzp91S7/YPprUODvuA+7HqqkKeWvZtfZN4JZigiO0Qyrwz zh0plWjXG9SyOQHCW2DMIg== 0001179110-05-015035.txt : 20050729 0001179110-05-015035.hdr.sgml : 20050729 20050729202557 ACCESSION NUMBER: 0001179110-05-015035 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050727 FILED AS OF DATE: 20050729 DATE AS OF CHANGE: 20050729 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YANG TAIYIN CENTRAL INDEX KEY: 0001334505 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 05986414 BUSINESS ADDRESS: BUSINESS PHONE: 650-574-3000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DRIVE CITY: FOSTER CITY STATE: CA ZIP: 94404 3 1 edgar.xml FORM 3 - X0202 3 2005-07-27 0 0000882095 GILEAD SCIENCES INC GILD 0001334505 YANG TAIYIN GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404 0 1 0 0 SVP, Pharm Dev & Mfg Common Stock 156615 D Common Stock 3992 I by Trust Incentive Stock Option (right to buy) 2.8594 2008-07-22 Common Stock 12000 D Incentive Stock Option (right to buy) 4.4688 2009-01-25 Common Stock 58664 D Incentive Stock Option (right to buy) 7.2969 2009-07-22 Common Stock 11624 D Incentive Stock Option (right to buy) 7.3985 2011-01-18 Common Stock 3208 D Incentive Stock Option (right to buy) 7.4063 2010-04-05 Common Stock 4800 D Incentive Stock Option (right to buy) 9.3438 2010-07-20 Common Stock 3000 D Incentive Stock Option (right to buy) 9.81 2011-04-18 Common Stock 2000 D Incentive Stock Option (right to buy) 11.7579 2010-11-08 Common Stock 1888 D Incentive Stock Option (right to buy) 16.4375 2012-01-30 Common Stock 7448 D Incentive Stock Option (right to buy) 17.8850 2013-01-29 Common Stock 4414 D Incentive Stock Option (right to buy) 29.1150 2014-07-28 Common Stock 290 D Incentive Stock Option (right to buy) 30.53 2014-01-28 Common Stock 3000 D Incentive Stock Option (right to buy) 32.02 2015-01-26 Common Stock 2000 D Incentive Stock Option (right to buy) 34.9950 2013-07-30 Common Stock 1578 D Incentive Stock Option 38.72 2015-05-09 Common Stock 928 D Non-Qualified Stock Option (right to buy) 7.3985 2011-01-18 Common Stock 60792 D Non-Qualified Stock Option (right to buy) 7.4063 2010-04-05 Common Stock 43200 D Non-Qualified Stock Option (right to buy) 9.3438 2010-07-20 Common Stock 17000 D Non-Qualified Stock Option (right to buy) 11.7579 2010-11-08 Common Stock 14112 D Non-Qualified Stock Option (right to buy) 16.4375 2012-01-30 Common Stock 72552 D Non-Qualified Stock Option (right to buy) 17.8850 2013-01-29 Common Stock 45586 D Non-Qualified Stock Option (right to buy) 29.1150 2014-07-28 Common Stock 29710 D Non-Qualified Stock Option (right to buy) 30.53 2014-01-28 Common Stock 57000 D Non-Qualified Stock Option (right to buy) 32.02 2015-01-26 Common Stock 38000 D Non-Qualified Stock Option (right to buy) 34.9950 2013-07-30 Common Stock 38422 D Non-Qualified Stock Option (right to buy) 38.7200 2015-05-09 Common Stock 29072 D Incentive Stock Option (right to buy) 7.0782 2010-01-26 Common Stock 2000 D Non-Qualified Stock Option (right to buy) 9.81 2011-04-18 Common Stock 18000 D Options vest 20% on 7/22/99, first anniversary date of the grant, and the remaining will vest quarterly over the next four years. Options vest 20% on 1/25/2000, first anniversary date of the grant, and the remaining will vest quarterly over the next four years. Options vest 20% on 7/22/2000, first anniversary date of the grant, and the remaining will vest quarterly over the next four years. Options vest 20% on 1/18/2002, first anniversary date of the grant, and the remaining will vest quarterly over the next four years. Options vest 20% on 4/5/2001, first anniversary date of the grant, and the remaining will vest quarterly over the next four years. Options vest 20% on 7/20/2001, first anniversary date of the grant, and the remaining will vest quarterly over the next four years. Options vest 20% on 4/18/2002, first anniversary date of the grant, and the remaining will vest quarterly over the next four years. Options vest 20% on 11/8/2001, first anniversary date of the grant, and the remaining will vest quarterly over the next four years. Options vest 20% on 1/30/2003, first anniversary date of the grant, and the remaining will vest quarterly over the next four years. Options vest 20% on 1/29/2004, first anniversary date of the grant, and the remaining will vest quarterly over the next four years. Options vest 20% on 7/28/2005, first anniversary date of the grant, and the remaining will vest quarterly over the next four years. Options vest 20% on 1/28/2005, first anniversary date of the grant, and the remaining will vest quarterly over the next four years. Options vest 20% on 1/26/2006, first anniversary date of the grant, and the remaining will vest quarterly over the next four years. Options vest 20% on 7/30/2004, first anniversary date of the grant, and the remaining will vest quarterly over the next four years. Options vest 20% on 5/9/2006, first anniversary date of the grant, and the remaining will vest quarterly over the next four years. Options vest 20% on 1/26/2002, first anniversary date of the grant, and the remaining will vest quarterly over the next four years. /s/ Taiyin Yang 2005-07-29 EX-24.TXT 2 poa-yang.txt POWER OF ATTORNEY AUTHORIZATION LETTER July 27, 2005 Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Attn: Filing Desk To Whom It May Concern: By means of this letter I authorize Mark L. Perry, John F Milligan, Gregg H. Alton, ESQ.and Matthew K. Au, or any of them individually, to sign on my behalf all forms required under Section 16(a) of the Securities Exchange Act of 1934, as amended, relating to transactions involving the stock of derivative securities of Gilead Sciences, Inc. (the "Company"). Any of these individuals is accordingly authorized to sign any Form 3, Form 4, Form 5 or amendment thereto which I am required to file with the same effect as if I had signed them myself. This authorization shall remain in effect until revoked in writing by me. Yours truly, /s/ Taiyin Yang POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Mark L. Perry, John F. Milligan, Gregg H. Alton, Esq. and Matthew K. Au signing individually, the undersigned's true and lawful attorneys-in-fact and agents to: (1) execute for and on behalf of the undersigned, an officer or director of Gilead Sciences, Inc. (the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute such Form 3, 4 or 5, complete and execute and amendment or amendments thereto, and timely file such forms or amendments with United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any nature whatsoever in connection with the foregoing which, in the opinion of such attorney-in- fact, may be of benefit, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney- in-fact's discretion. The undersigned hereby grants to each such attorney- in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, fully to all intents and purpose as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act. This Power of Attorney shall remain in full force and effect until the earliest to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, (b) revocation by the undersigned in a signed writing delivered to the foregoing attorney's-in-fact or (c) as to any attorney-in-fact individually, until such attorney-in-fact shall no longer be employed by the Company. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 27th day of July, 2005. /s/ Taiyin Yang -----END PRIVACY-ENHANCED MESSAGE-----